The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice

Obesity and obesity related kidney and liver disease have become more prevalent over the past few decades, especially in the western world. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic agents with promising effects on cardiovascular and renal function. Given SGLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong, Luo, Yuhuan, Wang, Xiaoxin, Orlicky, David J., Myakala, Komuraiah, Yang, Pengyuan, Levi, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796086/
https://www.ncbi.nlm.nih.gov/pubmed/29301371
http://dx.doi.org/10.3390/ijms19010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796086/
https://www.ncbi.nlm.nih.gov/pubmed/29301371
http://dx.doi.org/10.3390/ijms19010137

Ejemplares similares